How is the Royalty Pharma plc - Ordinary Shares - Class A today?

The Royalty Pharma plc - Ordinary Shares - Class A today is trading in the green, up by 3.58% at 35.27.

How has Royalty Pharma plc - Ordinary Shares - Class A performed historically?

The Royalty Pharma plc - Ordinary Shares - Class A is currently trading up 3.58% on an intraday basis in the past week the index rose 5.47%. The index has been up 8.66% in the past quarter and rose 28.63% in the past year. You can view this in the overview section.

What is Royalty Pharma plc - Ordinary Shares - Class A Annual Revenue?

Royalty Pharma plc - Ordinary Shares - Class A Annual Revenue fell 3.86%, in the last year to $2,263.58 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Royalty Pharma plc - Ordinary Shares - Class A Annual Net Profit?

Royalty Pharma plc - Ordinary Shares - Class A Annual Net Profit fell 24.31% in the last year to $858.98 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Royalty Pharma plc - Ordinary Shares - Class A Price to Earning Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Price to Earning Ratio is 13.6, higher than its sector PE ratio of 4.71.

What is Royalty Pharma plc - Ordinary Shares - Class A Stock Price?

Royalty Pharma plc - Ordinary Shares - Class A Stock Price rose 28.63% and outperformed its sector by 1.8% in the past year.

What is Royalty Pharma plc - Ordinary Shares - Class A Quarterly Revenue?

Royalty Pharma plc - Ordinary Shares - Class A Quarterly Revenue rose 0.05% YoY to $568.25 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Royalty Pharma plc - Ordinary Shares - Class A Quarterly Net profit?

Royalty Pharma plc - Ordinary Shares - Class A Quarterly Net profit rose 4,888.47% YoY to $238.35 M. Its sector's average net profit growth YoY for the quarter was -238.58%.

What is Royalty Pharma plc - Ordinary Shares - Class A Debt to Equity Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Debt to Equity Ratio of 1.1 is higher than 1. This implies that company assets are financed through debt.

What is Royalty Pharma plc - Ordinary Shares - Class A Return on Equity(ROE)?

Royalty Pharma plc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was 12.75%, in the normal range of 10% to 20%.

What is Royalty Pharma plc - Ordinary Shares - Class A Mutual Fund Holding?

Royalty Pharma plc - Ordinary Shares - Class A Mutual Fund Holding increased by 4.1% in the last quarter to 56.57.

What is Royalty Pharma plc - Ordinary Shares - Class A Interest Coverage Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Interest Coverage Ratio is 6.9, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Royalty Pharma plc - Ordinary Shares - Class A Institutional Holding?

Royalty Pharma plc - Ordinary Shares - Class A Institutional Holding increased by 2.26% in the last quarter to 77.39.

Royalty Pharma plc - Ordinary Shares - Class A XNAS: RPRX

Royalty Pharma plc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.963486125
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

35.27 1.22 (3.58%)

New 52W High today

8.9M

XNAS Volume

XNAS 12 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Royalty Pharma plc - Ordinary Shares - Class A is on 13 Jun 2025 for the purpose of Royalty Pharma PLC Annual General Meeting for 2025 See details

High Financial Strength

61.1 / 100

Mid Valuation

48.7 / 100

Technically Moderately Bullish

66.2 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

1Yr Price target upside is 18%

8 analysts

Royalty Pharma plc - Ordin... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma plc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

New 52W High today

SWOT Analysis

Royalty Pharma plc - Ordin... Live Price Chart

Royalty Pharma plc - Ordinary Shares - Class A FAQ

How is Royalty Pharma plc - Ordinary Shares - Class A today?

Royalty Pharma plc - Ordinary Shares - Class A today is trading in the green, and is up by 3.58% at 35.27.

How has Royalty Pharma plc - Ordinary Shares - Class A performed historically?

Royalty Pharma plc - Ordinary Shares - Class A is currently trading up 3.58% on an intraday basis. In the past week the stock rose 5.47%. stock has been up 8.66% in the past quarter and rose 28.63% in the past year. You can view this in the overview section.